ORGANIZATION
Labor Union Group Submits Request, Urges Drug Pricing Overhaul amid Inflation
The Healthcare Industry Platform, a group of pharma labor unions, on December 2 submitted a request to the health ministry calling for sweeping reforms to Japan’s drug and medical devices pricing systems, arguing that official prices must better reflect surging…
To read the full story
Related Article
- Labor Group Presses Lawmakers to Reflect Rising Costs in Drug Prices
November 26, 2025
ORGANIZATION
- Novartis’ Pullicino to Helm EFPIA Japan from July
May 22, 2026
- FPMAJ Calls for Greater Support for Stable Drug Supplies in Honebuto Policy
May 22, 2026
- JPMA Exec Urges Broader Debate on Japan’s CEA System
May 22, 2026
- COVID-19 Vaccination Rates Fall as Out-of-Pocket Costs Rise: Jiji Survey
May 21, 2026
- Awareness of HPV Vaccination for Males Stands at 39.4%: Survey
May 21, 2026
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…





